Internal Medicine, Endocrinology, Diabetes, & Metabolism · Dyersburg, TN
NPI
1689677296
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1716 Parr Ave Ste F
Dyersburg, TN, 38024
Phone (731) 288-3368
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
2,377 services
Medicare patients, 2024
828
Average age 72
Drug cost, 2024
$5.5M
15,295 prescriptions
Company payments, 2025
$3,599
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rauf Baba was code 99214 (office e&m - established), 1,125 times for 592 patients. In total Rauf Baba billed 2,377 services in 8 codes, and Medicare paid $137K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,125 | 592 | $85.26 | $96K |
| 83036 Blood Count | Office | 746 | 401 | $9.45 | $7,052 |
| 99213 Office E&M - Established | Office | 291 | 199 | $53.73 | $16K |
| 99204 Office E&M - New | Office | 122 | 122 | $107.43 | $13K |
| 99203 Office E&M - New | Office | 61 | 61 | $65.68 | $4,006 |
| 10005 Other Organ Systems | Facility | 23 | 22 | $48.98 | $1,127 |
By year: 2022 $183K for 4,331 services; 2023 $157K for 3,257 services; 2024 $137K for 2,377 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 746 | 401 | $9.45 | $7,052 |
Medicare prescription drug claims, 2024
In 2024, the drug Rauf Baba prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,466 prescriptions and refills. In total Rauf Baba wrote 15,295 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,466 | 3,215 | 376 | $11K |
| Ozempic Semaglutide | 1,057 | 1,215 | 216 | $1.1M |
| Jardiance Empagliflozin | 882 | 1,193 | 186 | $685K |
| Metformin Hcl Er Metformin Hcl | 679 | 1,358 | 181 | $5,402 |
| Glimepiride Generic | 605 | 1,191 | 163 | $6,931 |
| Mounjaro Tirzepatide | 531 | 572 | 106 | $594K |
| Synthroid Levothyroxine Sodium | 483 | 887 | 116 | $34K |
| Metformin Hcl Generic | 424 | 1,022 | 125 | $3,205 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 341 | 670 | 103 | $51K |
| Pioglitazone Hcl Generic | 337 | 673 | 91 | $3,811 |
| Novolog Flexpen Insulin Aspart | 314 | 467 | 79 | $78K |
| Farxiga Dapagliflozin Propanediol | 268 | 418 | 52 | $229K |
| Novolog Insulin Aspart | 265 | 339 | 58 | $63K |
| Trulicity Dulaglutide | 252 | 314 | 60 | $298K |
| Humalog Insulin Lispro | 249 | 331 | 54 | $64K |
Brand drugs: 8,326 claims; generic drugs: 5,823 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rauf Baba $3,599 ($3,599 in general payments such as food, travel and fees) from 26 companies. The largest payer was Novo Nordisk Inc with $408.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 21 | $408 |
| Amgen Inc. AMGN | 11 | $384 |
| Lilly USA, LLC LLY | 17 | $360 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $299 |
| Xeris Pharmaceuticals, Inc. | 15 | $283 |
| Sequel Med Tech, LLC | 10 | $265 |
| Corcept Therapeutics CORT | 12 | $250 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $197 |
| Abbott Laboratories ABT | 10 | $165 |
| Sanofi-Aventis U.S. LLC SNY | 6 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.